pharmaceutical services unit essential medicines management moh procurement of essential medicines...
TRANSCRIPT
1
Pharmaceutical Services Unit Essential Medicines Management
MoH Procurement of Essential Medicines
Presented by Mildred MulengaPharmacist, MoH
2
Pharmaceutical Services Unit Essential Medicines Management
Outline:ObjectivesMoH Budget for EMsProcurement CycleFactors that influence medicines pricesOverview of Procurement MethodsGood Pharmaceutical Procurement
PracticesOrganization and Management of
Procurement Unit
3
Pharmaceutical Services Unit Essential Medicines Management
Objectives:To present the MoH Medicines
BudgetTo describe the procurement
cycle for EMsTo present an overview of MoH
Procurement Systems
4
Pharmaceutical Services Unit Essential Medicines Management
IntroductionPharmaceutical procurement
system is major determinant of availability and total health costs
GRZ Medicines budget is K590 million (per capita ZMW47.20)
18.4 % of total GRZ Health budget
5
Pharmaceutical Services Unit, DCCDs
National Essential Medicines Budget
Objectives↑ availability and accessibility to all EMs and
medical supplies in all health facilities
6
Pharmaceutical Services Unit, DCCDsNational Essential Medicines Budget Key
Strengths for 2013:
112% ↑ increase of drug budget from ZMK
270 Billion (2012) to ZMK 594 billion
248% ↑ for ARVs & 20% increase for EMs, TB, Laboratory, RHCs kits, vaccines, Cancer,
Blood Products and 540% ↑ for medical supplies .
ZMK 120 Billion for ACTs
7
Pharmaceutical Services Unit, DCCDs
2013 Budget Key Issues:
ZMK 28 Billion for medical and surgical supplies still inadequate in view of the high cost centers of imaging, sutures, implants, and renal consumables
New products ACTs under GRZ budget need identification of reliable and consistent supply sources
Huge medicine budget require timely procurement
processes to ↑ budget absorption rates and ↓ lead times
8
Pharmaceutical Services Unit, DCCDs
2013 Budget Key Implementation Plan Issues
Need for timely procurements of all supplies under Yellow Book
Regular review of EMLs to improve selection
Implement all supply chain strengthening activities to improve availability of Ems
Implement all rational use of medicines activities as planned
9
Dis
trict Essentia
l Medicin
es (↑
20%
)
Hospita
l Essentia
l Medicin
es (↑
20%
)
Anti-R
etro
vira
l Dru
gs (↑
248%
)
AC
Ts (↑
20%
)
Vaccin
es a
nd Im
muniza
tion S
upplie
s
Tubercu
losis
Dru
gs (↑
20%
)
RH
Com
moditie
s (↑
20%
)
Labora
tory
Reagents
(↑20%
)
Cance
r Dru
gs (↑
20%
)
Medica
l and S
urg
ical S
upplie
s (↑
540%
)
Blo
od T
ransfu
sio
n C
om
moditie
s (↑
20%
)
0
20,000,000,000
40,000,000,000
60,000,000,000
80,000,000,000
100,000,000,000
120,000,000,000
140,000,000,000
160,000,000,000
180,000,000,000
78
,02
8,1
53
,06
5.0
76
,24
4,1
72
,24
2.0
50
,23
4,5
67
,90
8.0
25
,84
6,3
64
,20
8.0
7,4
25
,04
1,5
52
.0
6,1
85
,65
7,0
50
.0
5,4
18
,02
6,8
51
.0
9,9
91
,38
0,4
91
.0
4,4
96
,79
5,9
18
.0
16
,07
2,9
78
,23
4.09
36
33
78
36
79
.0
91
49
30
06
69
0.0
17
50
01
48
14
90
.0
12
00
00
00
00
00
.0
31
01
56
15
45
0.0
89
10
04
98
62
.0
74
22
78
84
60
.0
65
01
63
22
21
.0
11
98
96
56
59
0.0
28
80
06
32
22
1.0
19
28
75
73
88
1.0
2012/2013 National Medicines Budget
20122013
10
Pharmaceutical Services Unit, DCCDs
Dis
trict Essentia
l Medicin
es
28%
Hospita
l Essentia
l Medicin
es
27%
AR
Vs
18%
Vaccin
es
9%
TB
Medicin
es
3%
Repro
ductiv
e H
ealth
Com
-m
oditie
s2%
Labora
tory
Supplie
s2%
Cance
r Medicin
es
4%
Medica
l and S
urg
ical S
upplie
s2%
Blo
od T
ransfu
sio
n C
om
moditie
s
6%
2012 National Essential Medicines Budget
11
Pharmaceutical Services Unit, DCCDs
Dis
tric
t E
ssentia
l Medic
ines
16%
Hospit
al
Essen-
tia
l M
edic
ine
s15%
AR
Vs
29%
AC
Ts
20%
Vaccin
es
5%
TB
M
edic
ine
s1%
Repro-
ductiv
e
Healt
h
Com-
modit
ies
1%
Laboratory S
upplie
s1%
Cancer M
edic
ines
2%
Medic
al a
nd S
urgic
al S
upplie
s5%
Blo
od T
ransfu
sio
n C
om
modit
ies
3%
2013 National Essential Medicines Budget
12
Pharmaceutical Services Unit Essential Medicines Management
US$45,4m 33%
US$58,3m, 42%
US$35m , 25%
2013 National ARV Drug Budget
USGGFGRZ
13
Pharmaceutical Services Unit Essential Medicines ManagementFeatures of Effective Procurement
Processprocure right medicineshigh qualitylowest possible pricetimely deliveryTransparent & written proceduresseparation of key functionsReliable payment & good financial
managementProduct quality assurance programmePerformance monitoring
14
Pharmaceutical Services Unit Essential Medicines ManagementMoH Procurement CycleReview medicines selectionQuantificationReconcile needs and budgetSelect procurement methodLocate and select suppliersSpecify contract termsMonitor order statusReceive and check medicinesEffect paymentDistribute drugs Collect consumption data
15
Pharmaceutical Services Unit Essential Medicines Management
Factors influencing Drug Prices & Total costs
Unit PricesPurchasing modelsVisible & hidden costs
16
Pharmaceutical Services Unit Essential Medicines Management
Overview of Procurement Methods
Open Tender (ICB or NCB)Restricted Tender
(closed/selective)Competitive negotiationsDirect Procurement
17
Pharmaceutical Services Unit Essential Medicines Management
Good Pharmaceutical Procurement Practices:
Procurement by Generic nameNEMLBulky procurementFormal supplier Qualification
(screening)Competitive procurementOrders based on reliable needsReliable payments
18
Pharmaceutical Services Unit Essential Medicines Management
Good Pharmaceutical Procurement Prices cont.
Transparency and written procedures
Separation of key functionsProduction quality assurance (WHO
certification & post marketing surveillance)
Monitoring (auditing systems in place)
19
Pharmaceutical Services Unit Essential Medicines Management
Organisation and Management of Procurement System for EMs at MoH
Independent unit with Head PSUChief Procurement Officer,
Pharmaceuticals
20
Pharmaceutical Services Unit Essential Medicines Management
Responsibilities in the Procurement Process
PSUZPPAMTCs (Medicines and
Therapeutics Committees)
21
THANK YOU FOR LISTENING.